Potential new entrants to a major freight terminal in Queensland will be “better protected” by a last-minute promise by the terminal’s hopeful owner, Pacific National, than if the ACCC had succeeded in blocking the rail operator’s proposed $205 million acquisition, according to the judge who dismissed the competition watchdog’s case.
IP Australia has rejected an application by Huawei Technologies to register the trade mark Nova after a challenge by radio giant Nova Entertainment, with a delegate finding the Chinese telecommunications company had failed to prove its intention to use the mark.
A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.
Two female academics who made complaints of bullying against the head of La Trobe University’s law school and were named in his legal action against the university over his subsequent suspension have lost a bid to keep their identities under wraps.
An appeals court has criticised the ‘weak’ legal position of the owners of Chadstone Shopping Centre in Melbourne, throwing out their multi-million dollar appeal of a ruling in favor of anchor tenant Myer.
A judge has signed off on the lead applicants’ bid to expand the current group definition in a class action against Johnson & Johnson unit Ethicon over allegedly defective vaginal mesh products, saying there was “no reason in logic” why the request should be denied.
Apple founder Steve Jobs’ penchant for using the phrase “One more thing” as a rhetorical flourish during his highly anticipated “Stevenote” talks — usually before unveiling a new Apple product — does not constitute a trade mark use, according to a decision quashing Apple’s opposition to watch maker’s Swatch’ application to trade mark the phrase in Australia.
Former Aussie Home Loans boss Stephen Porges has lost an appeal of a judgment ordering him to pay more than $1 million to a private equity firm that was found to have been duped into buying his worthless shares in a beleaguered startup.
James Cook University unlawfully dismissed a professor who spoke out against the school and one of its scientists over its climate change views, a judge found Tuesday.
Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.